India, which is home to 16–17% of the world′s female population, accounts for 27% of cervical cancer cases globally. According to the most recent estimates, India accounts for roughly a third of all cervical cancer fatalities, with 60,000 deaths annually and 1,000,000 newly diagnosed cases.

According to Dr. Abhishek Shankar, Assistant Professor, Department of Radiation Oncology, All India Institute of Medical Sciences (AIIMS), if 78 of the worlds poorest countries swiftly implement HPV vaccinations, cervical screening, and cancer treatment as key interventions of the World Health Organization, over 7.4 crore cervical cancer cases and 6.2 crore deaths could be avoided in the next 100 years.

He explained that the three significant core pillars for universal HOV vaccination are completing HPV vaccination for 90% of girls by the age of 15, screening 70% of all women with a high-performance test by ages 35 and 45, and treating 90% of women with invasive cancer and pre-cancer. He added that HPV vaccines, namely Cervarix and Gardasil, can prevent infection and reduce the risk of cervical and other cancer types caused by HPV.

He emphasized that Cervarix is a bivalent vaccine that offers protection against HPV strains 16 and 18, which account for 70% of all instances of cervical cancer. According to reports, the vaccination is effective against HPV 16 and 18 and reduces the incidence of genital warts, precancerous lesions, and invasive cervical cancer.

According to the Indian Academy of Pediatrics Committee on Immunization (IAPCOI), all girls who can afford the vaccine should receive the HPV shot. According to Dr. Shubham Roy, a renowned developmental pediatrician and the director of Delhis Shining Stars Child Developmental Center, it is preferable to introduce the vaccination to parents as a cervical cancer prevention vaccine rather than a vaccine against a sexually transmitted infection.

According to Dr. Prerna Gautam, an assistant professor in the Department of Industrial and Management Engineering at the Indian Institute of Technology, Kanpur, "the optimization of the HPV schedule and supply chain process, along with planning and scheduling, can improve access to the vaccine, offering an opportunity to expand the number of girls who can be vaccinated and alleviating the burden of the complicated vaccination process." 

(Source: https://health.economictimes.indiatimes.com/news/industry/experts-uphold-universal-hpv-vaccination-to-save-women-from-cervical-cancer/97412956 )